Genetic testing cannot tell you with certainty whether or when a child will develop cancer. It can identify an inherited gene change that raises the child’s chance of particular cancers, sometimes enough to change screening, preventive care, treatment decisions or testing for relatives. Most childhood cancers are not explained by an inherited variant: the National Cancer Institute (NCI) estimates that inherited mutations cause about 8% to 10% of childhood cancers. A result must therefore be interpreted in the context of the child’s history, family history, age and available medical options.
This article explains what inherited-risk testing can and cannot show, how it differs from testing a tumor, and why a cancer genetic counselor and the child’s clinician should guide the decision. The information reflects U.S. NCI guidance and is educational, not individualized medical advice.
As an Amazon Associate I earn from qualifying purchases.
What a child’s inherited-risk test is actually looking for
Inherited, or germline, testing looks for DNA changes present in essentially every cell and passed through a family line. A pathogenic (disease-causing) variant can indicate a hereditary cancer syndrome: a pattern of increased susceptibility to one or more cancers. It does not show that cancer is currently present, and it does not make cancer inevitable.
Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteWindows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallThe NCI’s childhood-cancer overview says approximately 8% to 10% of childhood cancers are caused by inherited mutations (NCI, updated April 24, 2025). Sequencing cohorts have reported germline pathogenic-variant rates approaching 10%, although rates vary by tumor type and a detected variant may not explain an individual child’s cancer (NCI Childhood Cancer Genomics PDQ). For all cancers combined, the NCI gives a broader estimate of about 5% to 10% caused by inherited harmful changes; that figure is not specific to children (NCI Genetic Testing for Inherited Cancer Risk).
#1 Best Overall
- ABOUT THE TEST: The Genetrace DNA Paternity Test helps families conclusively determine if a man is the true father of a child.
- NO HIDDEN FEES: Kit includes all lab fees and sample return costs to test one (1) child and one (1) potential father.
- FAST RESULTS: Get secure, confidential results within 1-2 business days after testing begins. We'll keep you updated every step of the way.
- EASY SAMPLE COLLECTION: No needles, no blood, no doctors. Collect your samples with our easy-to-use mouth swabs, then return them to the lab with the provided prepaid return envelope. It's quick, easy & painless.
- ACCURATE & RELIABLE: Up to 27 genetic markers analyzed for over 99.999% accuracy. All tests performed TWICE in our AABB, ISO 17025 & CLIA accredited laboratory.
Risk from a variant is one part of a larger picture. Family history, the child’s medical history, environmental exposures and chance also contribute. A gene association cannot determine an individual child’s outcome.
Inherited testing and tumor testing answer different questions
When a child has cancer, doctors may sequence tumor cells to find DNA changes acquired during the cancer’s development. Those findings can help classify the tumor or identify treatment options. Tumor changes are not automatically inherited.
A tumor test can occasionally flag a change that might also be present in the germline, but a separate blood, saliva or other germline assessment is needed to establish inherited status. Tumor sequencing therefore does not replace inherited-risk testing when the clinical question is whether a child or relatives carry a familial predisposition (NCI).
Recommended Free Tools
When testing during childhood can be useful
The central question is not simply whether a gene can be tested. It is whether knowing the result now can improve the child’s health. NCI guidance supports testing when a result could change treatment or produce a positive health outcome during childhood. Testing is most clearly useful when a syndrome has effective childhood surveillance or prevention.
Rank #2
- About HomePaternity: This DNA test will conclusively determine if a man is the biological father of a child using a simple at-home kit including cheek swabs from the father and child.
- Fast Results: Your kit includes Overnight FedEx return to the lab and results will be available within 1-2 days after your sample arrives, in our secure online portal.
- Over 99.999% Confidence: With up to 34 genetic markers examined, we confirm paternity with the highest accuracy, typically 99.999%+. Tests are run twice in our lab, which has obtained over 6 certifications.
- Easy Sample Collection: Collect your samples with mouth swabs, then return in the pre-paid Overnight mailer. Includes testing for 1 child and 1 possible father; can add more participants after kit registration.
- Internal Lab: With over 25 years of experience and over 20 million tests performed, we don’t use third-party labs.
Syndromes with childhood screening or prevention
Multiple endocrine neoplasia (MEN) and familial adenomatous polyposis (FAP) are NCI examples in which childhood screening or preventive strategies exist. The NCI PDQ Cancer Genetics Editorial Board states: “When screening or preventive strategies during childhood are available (e.g., MEN and FAP), testing should be encouraged on clinical grounds” (NCI Cancer Genetics Risk Assessment and Counseling).
Adult-onset risks without a childhood intervention
If a syndrome usually causes cancer in adulthood and there is no validated childhood intervention, testing is generally deferred. NCI materials use BRCA1 and BRCA2 testing before age 18 as a specific example: knowing the result would not ordinarily change medical care in childhood. Deferral protects the child’s future ability to decide about adult-onset information while avoiding anxiety and uncertain findings that cannot be acted on now.
Situations that require specialist judgment
Some syndromes carry a childhood cancer risk but lack proven childhood risk-reduction strategies. The NCI describes TP53 pathogenic variants, associated with Li-Fraumeni syndrome, as a particularly controversial area. Decisions should be individualized with specialists rather than reduced to a universal rule to test or to wait.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Examples of genes and syndromes clinicians may discuss
These examples illustrate why the specific clinical context matters; they are not a self-diagnosis checklist.
Rank #3
- About HomePaternity: This DNA test will conclusively determine if a man is the biological father of a child using a simple at-home kit including cheek swabs from the father and child.
- Fast Results: Your samples will be returned via USPS within 7 business days. Your results will be available within 1-2 days after your sample arrives at our lab, in our secure online portal.
- Over 99.999% Confidence: With up to 34 genetic markers examined, we confirm paternity with the highest accuracy, typically 99.999%+. Tests are run twice in our lab, which has obtained over 6 certifications.
- Easy Sample Collection: Collect your samples with mouth swabs, then return in the pre-paid mailer. Includes testing for 1 child and 1 possible father; can add more participants after kit registration.
- Internal Lab: With over 25 years of experience and over 20 million tests performed, we don’t use third-party labs.
| Gene or syndrome | Childhood relevance described by NCI sources |
|---|---|
| TP53 / Li-Fraumeni syndrome | Associated with childhood cancers including adrenocortical carcinoma; the role of testing and management requires specialist discussion. |
| DICER1 | Associated with predisposition to pleuropulmonary blastoma. |
| SMARCB1 and SMARCA4 | Associated with rhabdoid tumors; SMARCA4 is also linked to small-cell ovarian cancer. |
| RB1 | Associated with retinoblastoma. |
| MEN and FAP syndromes | Examples where childhood screening or preventive strategies can make testing clinically useful. |
The presence of a variant does not guarantee cancer, and a family history of cancer does not prove that a hereditary syndrome is present. A genetics professional weighs the exact cancers, ages at diagnosis, pattern across relatives and the child’s own findings.
How inherited cancer-risk testing is performed
- Clinical assessment: A clinician or cancer genetic counselor reviews the child’s personal and three-generation family history when available, including cancer types and ages at diagnosis.
- Choose the testing question: The team decides whether testing is medically appropriate, which genes or variant types are relevant and whether an affected relative should be tested first.
- Collect a sample: Blood is commonly used; saliva and other sample types may also be accepted, depending on the laboratory and test.
- Laboratory analysis: A targeted test can look for a known familial variant. A focused or broader multigene panel can assess several genes at once when the clinical picture does not point to one change. Panel scope varies by clinical question.
- Receive and interpret the report: The NCI says results often return in about two to three weeks, but timing varies by laboratory. The ordering team should confirm the expected turnaround and arrange follow-up.
Whenever possible, testing often begins with a relative who has had cancer. Finding a familial variant in that person allows relatives to have targeted testing for the known change, which can be easier to interpret than an unexplained negative panel (NCI).
What the three main result categories mean
Pathogenic or likely pathogenic result
A pathogenic result can establish a predisposition to a hereditary cancer syndrome. The care team may recommend a syndrome-specific surveillance schedule, preventive procedure, altered treatment approach in some circumstances, or testing for relatives. The result still does not diagnose cancer or predict exactly if or when cancer will occur.
The Tool Desk
Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Outbyte Driver Updater FREEScan for outdated or missing drivers - takes under a minuteDriver Scan →Negative result
A true negative for a known familial variant can be reassuring about that specific inherited risk. A negative broad panel is different: if no familial variant is known, it cannot exclude every inherited cause, a gene not included on the panel, a variant type the test cannot detect, or non-genetic risk factors. Medical care should continue to reflect the child’s history and family pattern.
Rank #4
- TOP-SELLING CONSUMER DNA TEST: From your origins in over 3,600+ places around the world to the most connections to living relatives, no other DNA test kit delivers an experience as unique and interactive as AncestryDNA.
- YOUR DATA, YOUR CONTROL: We give you full control over your genetic information. You decide what to share, and with whom.
- DNA + TRAITS: Ever wondered where your freckles came from, or why you hate cilantro? AncestryDNA + Traits lets you discover 75+ genetic traits, allowing you to explore how your genes might have influenced a range of appearance, sensory, performance, nutrient, and other personal characteristics.
- A FEW SIMPLE STEPS: Simply activate your DNA kit online and return your saliva sample in the prepaid package to our state-of-the-art lab. Your results will be available online in roughly six weeks.
- ORIGINS AND INHERITANCE: AncestryDNA is the only DNA test that can show your origins results, DNA matches, and traits by each side of the family, without your parents taking a DNA test.
Variant of uncertain significance
A variant of uncertain significance (VUS) means the laboratory does not yet have enough evidence to classify the change as harmful or harmless. It should not be treated as a diagnosis, proof of elevated risk or a reason by itself for major medical decisions. The laboratory may reclassify it as evidence develops, so the genetics team should explain how updates will be handled (NCI PDQ).
Choosing among testing approaches
There is no universally “best” test. The appropriate approach depends on whether a familial variant is already known and whether the result could alter childhood care.
| Approach | When it may fit | Key trade-off |
|---|---|---|
| Known-variant targeted test | A pathogenic familial variant has already been identified. | Highly focused and easier to interpret for that specific risk; it does not evaluate unrelated genes. |
| Focused multigene panel | The history suggests a group of related syndromes or the responsible gene is uncertain. | Broader assessment than a single-variant test, with potential for findings that need specialist interpretation. |
| Broad multigene panel | The clinical picture is complex and several hereditary explanations are plausible. | May identify more uncertain or incidental findings; coverage and variant detection differ by laboratory. |
| Tumor sequencing | Characterizing an existing cancer or seeking treatment-relevant acquired changes. | Does not establish inherited risk; a separate germline assessment may be required. |
Before consenting, ask which genes and variant types are included, what the laboratory can miss, how incidental findings are handled and who will coordinate follow-up.
Why genetic counseling should come first
Pre-test counseling helps a family assess the likely value and limitations of testing before a sample is taken. The discussion can cover possible positive, negative and uncertain results; emotional effects; inheritance and implications for siblings, parents and other relatives; privacy considerations; and costs.
Best Value
- 𝐀𝐛𝐨𝐮𝐭 𝐭𝐡𝐞 𝐏𝐫𝐨𝐜𝐞𝐬𝐬: DNA Direct genetic testing kit to help you determine the biological father of a child; You can use this paternity test kit at home; Activate the DNA test online, collect the samples, mail them, and receive your results
- 𝐐𝐮𝐢𝐜𝐤 𝐑𝐞𝐬𝐮𝐥𝐭𝐬: Our kits offer quick, easy & painless at-home DNA testing, with no blood or doctor required; the kit includes instructions, mouth/cheek swabs & swab envelopes for sample collection in the comfort & privacy of your own home
- 𝐑𝐞𝐥𝐢𝐚𝐛𝐥𝐞 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐥 𝐋𝐚𝐛: Samples are tested by our AABB & ISO 17025 accredited laboratory; With decades of experience and millions of tests performed, your DNA kit is processed by the laboratory behind the genetic test
- 𝐃𝐢𝐬𝐜𝐫𝐞𝐞𝐭 𝐒𝐞𝐫𝐯𝐢𝐜𝐞: Each home paternity DNA test kit includes our phone number; If you have any questions about our DNA testing service, please don’t hesitate to contact us; We ensure your privacy and keep your information confidential
- 𝐍𝐨 𝐇𝐢𝐝𝐝𝐞𝐧 𝐅𝐞𝐞𝐬: Cost of the paternity DNA test kit includes all lab fees and a prepaid return envelope (US only); Each paternity test kit comes with instructions, mouth/cheek swabs, and swab envelopes for sample collection
Post-test counseling is especially important after a pathogenic result. A counselor can translate the laboratory language into a surveillance plan, clarify which relatives might benefit from targeted testing and prevent a VUS from being mistaken for a diagnosis. Counseling does not replace the child’s pediatric, oncology or other specialist care; it connects the result to that care.
Questions to take to the clinician or counselor
- What feature of my child’s history or our family history suggests an inherited syndrome?
- Could a result change my child’s care before adulthood?
- Which genes and variant types does the proposed test cover, and what can it miss?
- How would a pathogenic, negative or uncertain result change the plan?
- Should an affected relative be tested first?
- Who will explain the report and coordinate follow-up for my child and relatives?
- What will counseling and testing cost, and what may insurance cover?
The NCI says health insurance typically covers counseling and tests considered medically necessary, but coverage depends on circumstances and location. Confirm the estimate, authorization requirements and potential out-of-pocket costs with the provider and insurer (NCI).
What not to use as a substitute
Consumer DNA kits and self-directed testing are not a substitute for a clinician-directed hereditary cancer evaluation. They may not examine the genes or variant types relevant to a child’s history, and a raw result can be difficult to interpret. A medical genetics team can select an appropriate laboratory, explain limitations and connect a finding to evidence-based care.
The practical answer for parents
Genetic testing can reveal that a child inherited a predisposition to certain cancers and can sometimes enable earlier surveillance, prevention or more tailored treatment. It cannot promise that cancer will or will not occur. Testing is most valuable when the result can improve health during childhood, especially for syndromes with established screening or preventive options. For adult-onset risks without childhood interventions, waiting is often appropriate; for complex syndromes, the decision needs specialist discussion.
Start with the child’s clinician or a cancer genetic counselor, bring the most complete family cancer history available, and ask how each possible result would change care now. That approach is more informative and safer than ordering a test without a plan for interpretation.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
